โšกYour ready-to-use recruitment solution: IRB-compliant, SEO-optimized website that automatically routes qualified patient leads to your clinical study (14-day free trial, then $44/mo)

Subpectoral Bupivacaine for Pain Management in Adolescent Reduction Mammaplasty

Sponsored by Connecticut Children's Medical Center

Quick Self-Assessment

See if you qualify and express your interest

Preparing your pre-screening questions...

Current Status

Recruiting

Auto-verified from ClinicalTrials.gov

Verified May 29, 2025

Phase

Clinical Trial

Sponsor

Connecticut Children's Medical Center

Enrollment Target

128

Start Date

Apr 2022

๐Ÿ“Š
1 of 128 participants interested
1% interest

Express Your Interest Today

Interested in learning more? Complete the form below.

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Advance Medical Science

    Contribute to groundbreaking research

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel (varies by study)

  • Help Others

    Benefit future patients

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3In-person assessment if eligible
  4. 4Begin participation

About This Study

The main question this randomized control trial aims to answer is: โ€ข Is the use of intraoperative subpectoral bupivacaine associated with decreased post-operative pain in adolescent patients who undergo bilateral reduction mammaplasty Participants will be randomized into the study group that intraoperatively receives 30cc of subpectoral bupivacaine injections or into the control group that intraoperatively receives 30cc of injectable saline subpectorally.

Who Can Participate

Inclusion Criteria

Female 2. Age 13-25 at the time of surgery 3. Undergoing bilateral reduction mammaplasty at Connecticut Children's from 1/1/2022-12/31/2025. 4. Ability of child's parent/legal guardian to understand and the willingness to sign a written informed consent document.

Exclusion Criteria

Patients with history of substance use disorder or "chronic pain" defined as pain requiring management and treatment by a pain management specialist. 2. Patients already taking narcotics at the time of surgery. 3. Patients with a history of hepatic or renal dysfunction. 4. Patients with known allergy to bupivacaine. 5. Patients who are pregnant, determined by urine testing in pre-operative area. 6. Patients who are non-verbal or have developmental delays that would result in inability to report reliable pain scores. 7. Patients with significant post-operative complications 8. Patients not meeting inclusion criteria. 9. Patients lost to follow-up- they must be seen within 1 week

โ“ Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility during the screening process.

Study Details

๐Ÿ“‹

Study Type

INTERVENTIONAL

๐Ÿ‘ฅ

Target Enrollment

128 participants

๐ŸŽ‚

Age Range

13 Years - 25 Years

โšง

Gender

ALL

๐Ÿข

Sponsor

Connecticut Children's Medical Center

Study Locations

Choose your preferred location or select flexible during enrollment

RECRUITING

Farmington

Connecticut

Location available
View Farmington location page
RECRUITING

Hartford

Connecticut

Location available
View Hartford location page

Frequently Asked Questions

Q:What is a clinical trial?

A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.

Q:Will I be compensated?

Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.

Q:Will I receive a placebo instead of treatment?

When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.

Q:Can I leave a trial if I change my mind?

Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.

Q:How long does a clinical trial last?

Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.

Still have questions? Our study coordinators are here to help.

Ready to Make a Difference?

Express your interest in this groundbreaking clinical trial

๐Ÿ”’ Secure ยท ๐Ÿฅ Expert Care

Find More Ankylosing Spondylitis Trials by City

Browse all ankylosing spondylitis clinical trials in these cities โ€” not just this study.

Looking for Macromastia Treatment in Farmington?

Join others in Connecticut exploring innovative treatment options through clinical research

Macromastia Treatment Options in Farmington, Connecticut

If you're searching for Macromastia treatment in Farmington, participating in a clinical research study may provide access to innovative approaches under expert medical supervision. This study is actively recruiting participants in Farmington, Hartford and surrounding areas.

Clinical trials offer participants the opportunity to receive cutting-edge treatments while contributing to medical research that may help future patients with Macromastia. All study-related care is provided at no cost to participants.

Local Sites
2 locations in Connecticut
Now Enrolling
Up to 128 participants
Quick Start
Screening available now

Why Consider a Clinical Trial for Macromastia?

Potential Benefits

  • โœ“Access to new treatment approaches before public availability
  • โœ“Close monitoring by experienced medical professionals
  • โœ“Study-related care provided at no cost
  • โœ“Contribute to medical research for Macromastia

What to Expect

  • โ†’Initial screening to determine eligibility
  • โ†’Regular check-ups and monitoring visits
  • โ†’Possible compensation for time and travel
  • โ†’You can withdraw at any time

Frequently Asked Questions About This Macromastia Study

Important Clinical Trial Information

This information is provided for educational purposes and does not constitute medical advice. Clinical trial participation involves potential risks and benefits. Eligibility requirements apply and will be assessed during the screening process.

Study identifier: NCT05898087. For complete study details, visit ClinicalTrials.gov. Always consult with your healthcare provider before making decisions about your medical care or participating in clinical research.